Peter Ros

Peter Ros has a wealth of experience in the finance and accounting field. Peter began their career in 1993 as an Accountant at PricewaterhouseCoopers. In 1999, they took on the role of Interim Controller at Vanenburg Software, followed by Financial Interim Controller at Engelhard Corporation - part of BASF Group and Financial Interim Manager at Rosmont B.V. From 2001 to 2020, Peter worked at Genmab in various roles, including Sr. Director Accounting & Finance, Sr. Director Finance & Accounting, R&D Operations, and Sr. Director, Finance. In 2020, they became Vice President Finance at LAVA Therapeutics N.V. and Non-Executve Board member at Blue21. Peter also held the role of Bestuurslid at VVE Oogstweg 29 from 2009 to 2020.

Peter Ros has a long and varied educational history. Peter completed their HEAO RA in Accountancy at Windesheim from 1989 to 1993. Peter then went on to complete their RA in Accountancy at Vrije Universiteit Amsterdam (VU Amsterdam) from 1993 to 1998. In December 1998, Peter obtained a Register Accountant certification from the Koninklijke Nederlandse Beroepsorganisatie van Accountants. Peter also attended Maastricht University and Alex van Groningen, but did not obtain any degrees from these institutions.